ANGLE plc (LON:AGL – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 11.26 ($0.14) and traded as low as GBX 10.50 ($0.13). ANGLE shares last traded at GBX 11.22 ($0.14), with a volume of 865,932 shares traded.
Analyst Ratings Changes
Separately, Berenberg Bank restated a “buy” rating and set a GBX 70 ($0.85) price target on shares of ANGLE in a research report on Thursday, September 26th.
Read Our Latest Research Report on ANGLE
ANGLE Stock Performance
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Recommended Stories
- Five stocks we like better than ANGLE
- What Makes a Stock a Good Dividend Stock?
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Industrial Products Stocks Investing
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- CD Calculator: Certificate of Deposit Calculator
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.